A modified MethyLight assay predicts the clinical outcomes of anti‐EGFR treatment in metastatic colorectal cancer

Corresponding Author

Chikashi Ishioka

Department of Clinical Oncology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Miyagi, Japan

Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan

Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Miyagi, Japan

Corresponding author

Chikashi Ishioka, Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aobaku, Sendai 980-8575, Japan

Email: chikashi@tohoku.ac.jp

Search for more papers by this author

留言 (0)

沒有登入
gif